[1] |
Wang Yihan, Qin Xuyan, Han Xuanze, Wang Yingjie, Gao Feifei, Chen Chunhong, Zhang Lingnan, Zhang Fang.
Efficacy and safety of rivaroxaban therapy in elderly patients with non-valvular atrial fibrillation who had a HASBLED score≥3
[J]. Clinical Focus, 2024, 39(2): 121-124.
|
[2] |
Wang Zhen, Yang Xiaoyue, Li Shaojie, Wang Xian, Chen Shuxia, Gu Jian.
Analysis of clinical characteristics and readmission risk factors in patients with ejection fraction preserved heart failure combined with atrial fibrillation
[J]. Clinical Focus, 2023, 38(4): 308-314.
|
[3] |
Zhang Fang, Zhang Yichao, Jia Xinwei, Li Jianlong, Chen Chunhong.
Analysis of one-year follow-up results of ≥75-year-old atrial fibrillation inpatients with high CHA2DS2-VASc score
[J]. Clinical Focus, 2023, 38(2): 117-120.
|
[4] |
Ma Jinghong, Yang Qian, Jia Yongjian, Dang Yi.
Risks of cardiac tamponade resulting from uninterrupted novel oral anticoagulants and uninterrupted warfarin during perioperative period of catheter ablation of atrial fibrillation: A meta-analysis
[J]. Clinical Focus, 2022, 37(9): 773-778.
|
[5] |
Zhang Haifu, Ye Xiangqing, Chen Zhexu, Chen Shijian, Yang Dong, Zhang Xingwei.
Effects of moderate exercise on the prognosis of patients with atrial fibrillation:A systematic review and Meta-analysis
[J]. Clinical Focus, 2022, 37(6): 485-489.
|
[6] |
Zhang Jingshui, Xu Yanan, Wang Jun, Yang Yi, Jiang Haibing, Tang Long, Wang Xianping, Shao Mingliang.
Clinical characteristics and long-term prognosis of initial patients with new onset different type of heart failure combined atrial fibrillation
[J]. Clinical Focus, 2022, 37(6): 504-509.
|
[7] |
Li Weiwei, Li Yanan.
Left atrial volume index predicts atrial fibrillation recurrence after radiofrequency ablation: A meta-analysis
[J]. Clinical Focus, 2022, 37(11): 965-968.
|
[8] |
An Jingjing, Wang Xiaojuan, Deng Aiyun.
Radiofrequency ablation in treating pre-excited atrial fibrillation recurrence: A meta analysis
[J]. Clinical Focus, 2022, 37(10): 899-904.
|
[9] |
Zhao Meili, Xiao Liyuan, Liu Lin, Kang Chao, Zhang Qiuxiang.
Correlation between NT-proBNP, hs-CRP, left atrium diameter and chronic heart failure concurrent with atrial fibrillation
[J]. Clinical Focus, 2021, 36(5): 412-415.
|
[10] |
Geng Yanping, Wang Lili, Gu Jian, Qi Peng, Chen Shuxia.
Validity and reliability analysis of Chinese version of AntiClot Treatment Scale
[J]. Clinical Focus, 2020, 35(9): 788-791.
|
[11] |
Ma Jincai, Ma Rongzhi, Ma Zhenzhen.
Efficacy and safety of rivaroxaban in elderly patients with nonvalvular atrial fibrillation complicated with cardiac insufficiency
[J]. Clinical Focus, 2020, 35(5): 413-416.
|
[12] |
Yang Hua, Meng Limin, Xin Shuanli, Chang Chao, Zhao Xiufeng, Wang Min.
Correlation between serum chemerin levels and degree of atrial fibrosis in patients with atrial fibrillation
[J]. Clinical Focus, 2020, 35(3): 206-210.
|
[13] |
Lu Yuqin, Li Yingdong, Liu Kai.
Role of serum MMP-1, MMP-3, TIMP-1 and Hcy levels in patients with hypertension complicated with atrial fibrillation
[J]. Clinical Focus, 2020, 35(11): 976-979.
|
[14] |
Gao Xiuxina, Si Yueqiaoa, Ding Zhenjianga, Zhang Yinga, Liu Huilinga, Liu Jingyia, Han Chaoa, Sunwang Lexianaa.
Correlation of platelet distribution width and red blood cell distribution width in peripheral blood with atrial fibrillation in patients with coronary artery disease
[J]. Clinical Focus, 2020, 35(11): 984-987.
|
[15] |
Nuozha Dainier, Muhuyati.
Metaanalysis of factors influencing recurrence after radiofrequency ablation of atrial fibrillation
[J]. Clinical Focus, 2019, 34(3): 267-272.
|